CERC Cerecor Inc.

3.39
-0.08  -2%
Previous Close 3.47
Open 3.43
Price To Book 8.92
Market Cap 159,207,679
Shares 46,963,917
Volume 18,354
Short Ratio
Av. Daily Volume 69,674
Stock charts supplied by TradingView

NewsSee all news

  1. Cerecor To Sell Pediatric Portfolio to AYTU BioScience

    -Deal Valued in Excess of $32 Million-Eliminates Debt Associated with Avadel / Deerfield Agreement-Provides Non-Dilutive Cash Generation to Fund R&D  -Extends Runway Towards NDA Submission of CERC-801 ROCKVILLE,

Drug Information

Drug catalyst information is displayed when you hover over / tap on the stage bar graph.

Phase 2 top-line data released December 5, 2016 - endpoint not met.
CERC-501
Smoking cessation
Phase 2 top-line data released November 29, 2016 failed to meet primary endpoint.
CERC-301
Major depressive disorder (MDD)
Phase 1 final data released July 1, 2019.
CERC-301
Neurogenic Orthostatic Hypotension (nOH)
NDA planned of 2H 2020.
CERC 801
Phosphoglucomutase 1 (PGM1) deficiency

Latest News

  1. Cerecor To Sell Pediatric Portfolio to AYTU BioScience

    -Deal Valued in Excess of $32 Million-Eliminates Debt Associated with Avadel / Deerfield Agreement-Provides Non-Dilutive Cash Generation to Fund R&D  -Extends Runway Towards NDA Submission of CERC-801 ROCKVILLE,